In this episode our host Dr Sarah Drummond speaks with Professor Catherine Smith and Dr Andrew Pink about eczema therapeutics: • The use of JAK inhibitors licensed for use in managing eczema including their mechanism of action, monitoring requirements and potential side effects. • Newer agents currently under investigation. • The BEACON trial Recorded: 19 March 2024 For more information, visit: www.stjohnsdermacademy.com/podcasts Disclaimer: The information on our ...
All content for St John's DermAcademy Podcast is the property of St John's DermAcademy and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode our host Dr Sarah Drummond speaks with Professor Catherine Smith and Dr Andrew Pink about eczema therapeutics: • The use of JAK inhibitors licensed for use in managing eczema including their mechanism of action, monitoring requirements and potential side effects. • Newer agents currently under investigation. • The BEACON trial Recorded: 19 March 2024 For more information, visit: www.stjohnsdermacademy.com/podcasts Disclaimer: The information on our ...
Episode 14: Part 1: Immunobullous disorder - Bullous pemphigoid
St John's DermAcademy Podcast
18 minutes
1 year ago
Episode 14: Part 1: Immunobullous disorder - Bullous pemphigoid
In this episode our host Dr Sarah Drummond speaks with Dr Thomas Tull about bullous pemphigoid: • The clinical features and risk factors for developing bullous pemphigoid • How to differentiate bullous pemphigoid from other subepidermal blistering disorders • Management of bullous pemphigoid including: o Preferred first and second line agents o How and when to reduce treatment o What to do in severe and refractory cases Resources and further re...
St John's DermAcademy Podcast
In this episode our host Dr Sarah Drummond speaks with Professor Catherine Smith and Dr Andrew Pink about eczema therapeutics: • The use of JAK inhibitors licensed for use in managing eczema including their mechanism of action, monitoring requirements and potential side effects. • Newer agents currently under investigation. • The BEACON trial Recorded: 19 March 2024 For more information, visit: www.stjohnsdermacademy.com/podcasts Disclaimer: The information on our ...
